z-logo
Premium
Hyperuricaemia and gout in N ew Z ealand rural and urban M āori and non‐ M āori communities
Author(s) -
Stamp L. K.,
Wells J. E.,
Pitama S.,
Faatoese A.,
Doughty R. N.,
Whalley G.,
Richards A. M.,
Cameron V. A.
Publication year - 2013
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.12062
Subject(s) - gout , medicine , anthropometry , uric acid , population , demography , gerontology , physical therapy , environmental health , sociology
Background There are few current data on the prevalence of hyperuricaemia and gout in N ew Z ealand, particularly among the indigenous M āori population. Aims To determine the prevalence of gout and hyperuricaemia in rural and urban M āori and non‐Māori community samples and describe the treatment and comorbidities of participants with gout. Methods Participants aged 20–64 years were recruited by random selection from the electoral roll. M āori samples were selected from among those identified as being of M āori descent on the roll and who self‐identified as being of M āori ethnicity at interview. Personal medical history, blood pressure, anthropometrics, fasting lipids, glucose, HbA1c and urate were recorded. Results There were 751 participants. Mean serum urate ( SU ) was 0.30 mmol/L (0.06–0.69 mmol/L). M āori had a significantly higher prevalence of hyperuricaemia ( SU > 0.40 mmol/L) compared with non‐ M āori (17.0% vs 7.5%, P = 0.0003). A total of 57 participants had a history of gout, with a higher prevalence in M āori compared with non‐ M āori (10.3% vs 2.3%, P < 0.0001). Of the participants, 18/57 (31.6%) with gout were receiving urate‐lowering therapy, but in 38.9%, SU was >0.36 mmol/L. Participants with gout were more likely to have metabolic syndrome, diabetes, cardiac disease or hypertension. Conclusions Gout and hyperuricaemia were more prevalent in M āori, and participants with gout were more likely to have comorbidities. There was not a higher overall adjusted cardiovascular disease risk in M āori participants with gout. Despite the high prevalence of gout, management remains suboptimal.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here